Parkinson's Disease Epidemiology Forecast 2025-2034

Parkinson’s disease is the second-most common neurodegenerative condition after Alzheimer’s disease, affecting approximately 1 million people in the United States. The incidence of Parkinson’s disease is reported to increase with age, with men 1.5 times more likely to develop the condition than women.

Parkinson’s Disease Epidemiology Forecast Report Coverage

The “Parkinson’s Disease Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of Parkinson’s disease. It projects the future incidence and prevalence rates of Parkinson’s disease across various populations. The study covers age, gender, and type as major determinants of the Parkinson’s disease-affected population. The report highlights patterns in the prevalence of Parkinson’s disease over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Parkinson’s disease in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Parkinson’s Disease Overview

Parkinson's disease is a degenerative condition involving the central nervous system that affects movement. It often starts with a tremor in one hand, with symptoms like stiffness, slow movement, and loss of balance. The risk of developing Parkinson’s is reported to increase with age and is slightly more prevalent in men. Studies show that this disease causes the basal ganglia in the brain to deteriorate, leading to the loss of abilities that are controlled by these areas.

Parkinson’s Disease: Treatment Overview

Currently, there is no cure for Parkinson's disease, with the treatments focusing primarily on symptom relief. Medications, rehabilitation, surgery, and lifestyle changes include the common treatment options. A combination therapy levodopa/carbidopa is used to increase dopamine levels in the brain. Dopamine agonists (mimic the effects of dopamine) and anticholinergics (reduce muscle rigidity and tremors) are also prescribed to the patients.

Epidemiology

The Parkinson’s disease epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for Parkinson’s disease by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Parkinson’s disease and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Parkinson’s disease is estimated to affect more than 10 million people worldwide, with about 1 million patients living in the United States.
• Age is considered the primary risk factor for Parkinson’s disease. It is reported that at least 1% of people aged over 60 years are affected by the condition. However, it is also observed to affect adults as young as 20 years in rare cases.
• As per the Parkinson’s Foundation Parkinson’s Prevalence Project, around 1.2 million people are projected to be living with Parkinson’s disease in the United States by 2030.
• Parkinson’s disease is reported to occur more commonly in males than females by 1.5 times. Further, genetics is observed to be a known cause in nearly 10% to 15% of the cases.

Country-wise Parkinson’s Disease Epidemiology

The Parkinson’s Disease epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of Parkinson’s disease varies between countries owing to differences in genetic predispositions, environmental exposures, healthcare access, aging populations, and lifestyle factors, among others. In the United States, approximately 90,000 individuals are diagnosed with Parkinson’s disease every year.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Parkinson’s disease based on several factors.
• Parkinson’s Disease Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of Parkinson’s disease are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of Parkinson’s disease epidemiology in the 8 major markets?
• What will be the total number of patients with Parkinson’s disease across the 8 major markets during the forecast period?
• What was the country-wise prevalence of Parkinson’s disease in the 8 major markets in the historical period?
• Which country will have the highest number of Parkinson’s disease patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of Parkinson’s disease during the forecast period of 2025-2034?
• What are the currently available treatments for Parkinson’s disease?
• What are the disease risks, signs, symptoms, and unmet needs of Parkinson’s disease?

This product will be delivered within 3-5 business days.